2004 Scientific Discussion This Module Reflects

SCIENTIFIC DISCUSSION 1. Introduction

SCIENTIFIC DISCUSSION This module reflects the initial scientific discussion for the approval of Herceptin. This scientific discussion has been updated until 30 November 2004. For information on changes after this date please refer to module 8B. 1. Introduction Herceptin contains the active substance trastuzumab (anti-p185, rhuMab HER2), which is a

  Scientific, This, Module, 2004, Discussion, Scientific discussion, Reflect, Scientific discussion this module reflects